 Hey, Ben, how you doing? Rich, I'm good. How are you? I'm doing fantastic. Long time no speak. How are things? Things are great. Thanks. Super busy. Very good. Very good. So let's talk about it. Pure Extracts got its sales license from Health Canada. We did. Can you please let the viewers know what this means for the company? That is huge news. Congratulations. Yeah, we're super excited about that. So it means that we can sell directly to the provincial entities, like we're in Alberta, BC, Saskatchewan and Ontario. And we sell through ABBA Medical Sales License. So we rent, effectively rent their license. So we no longer have to pay that fee to them. So we get to keep all the margin, which is always good. And sell directly to the provinces. So it speeds up our route to market. And in some places they didn't have a relationship with the distribution network. So we can go direct versus going through it intermediary. Definitely helps from a sales perspective and just speeds everything up for us. That's huge. And I know you guys are working on sales in Alberta. Can you give us an idea of the market size and how much of the market cap you think you can capture? Yeah, Alberta is a great market, to be honest with you. Ontario is probably the biggest market built by Alberta. So we're pretty excited about that. We think we can capture a large part of the vape market plus a substantial amount of the gummy market. We signed a deal, as you know, with Fireball from the state. So we're using their formula under the pure chews name because Alcantara will allow us to call it Fireball. But same formulation. And we're using some proprietary packaging. So that will be in-market in Alberta in two weeks. That'll be on shelf. It's on shelf in BC. So we're pretty excited about that. We think we can capture a nice portion of the market with the flavor profile. They're in five states and they're either number one or number two in those states that they sell in. We're using the same, obviously, flavor profiles and whatnot. So three different flavors will be coming out and then two in CBD products. So we're excited about that. So in our vape products is in market already. They're selling quite well in Alberta. We're doing a half gram, one gram coming soon for the people that want a little bit of value for if they like the product. That's where I think the market is going to. So we're actually producing those now. So those will be in market in all four provinces for the end of August. Great. Wow. You guys are really evolved since your IPO in November. So it just seems like every time we talk, you guys just continue to have news. You guys continue to grow. You guys are continuously moving forward and that's a great sign. Now, other places you're working on sales is British Columbia, where I'm at, and Saskatchewan. When do you believe you'll have a good foothold in those markets? You know, I guess, you know, we're, we're shipping product as we speak into both of those GEOs. So it'll be in market. You know, we do education through Canoval, our agent that goes in and educates the, but East is in the, in the dispensaries. So they go to every location, give them a sales sheet, you know, talk with the product, with them sample the product if it's allowed in the, in the province. Some, some provinces are different than others and getting them up to speed. But our product, especially in BC, Alberta, Saskatchewan, because of the formulations we're trying in the illicit market, we have a lot of crossover folks that have seen the product before under its former life. So we're having good pickup from those people that have tried it before. A lot of those people used to run illicit dispensaries. Now they're legit. So we're getting good sale through from that perspective. So Ontario obviously the biggest, the biggest market today and the most stringent from taking on new products. So we have a few listings there and we've submitted like nine more to be reviewed. So that'll be, that'll be a good area for us. And, you know, we're not sticking to Canada only as you know, Michigan, you know, we're coming shortly. We should be able to sign the definitive agreement with the MSO and then we'll start production, you know, in that way, November or December we'll be up and producing in the Michigan market. Wow, that's incredible. Can you tell us about the medical platform ABBA that you guys are working on? Yeah, so ABBA Medica is the folks that we use to sell through from our license for the provinces. So their business is also dealing with a lot of the vets and the government helps fund their cannabis use. So they have a medical platform in kind of like shoppers and they carry several different brands and their slant on their business model is they really deal with high volume users, a lot of, you know, the Canadian vets that were in the military. So we've joined them beyond their platform in August and mid August the product will be on shelf. We think that they have profiles and the, the, uh, the policy profiles that they have picked lend themselves to what the vets are looking for. So we're pretty excited about that. And we're working on a couple other hard scale medical platforms to list the products on in September. Very good. Now you've mentioned Michigan. Can you give us an update on Michigan right now? Yeah, Michigan is super exciting. So as your viewers will know, Michigan has really taken off as one of the states that, uh, has been, uh, has been crushing it for a, for lack of a better word, they're doing 180 million dollars a month in recreational sales. And it's, it's more than Canada, right? So they're in Ontario and BC put together. Um, so per user higher than Colorado and California. So, you know, Michigan, I guess in the winter is a pretty bleak place sometimes. So I got to find something to do. So it's taken up a big decision, but, um, it is really taken off for sales. There's 400 dispensaries in the state already. So really quick, really quick, right? So we're barely at 400 in Ontario, right? So we've been at this for a couple of years. So, um, traction has been great. We have a really good partner that we're working with that does extremely well and dried flower. Um, and want to enter the extraction business and really didn't want to have the, uh, the learning curve to get an extraction business up and running. And that's where we came in. Um, so, uh, Vapes and gummies represent, I think like over 50% of their sales might be a little bit more in the last report that I saw. Um, so their, uh, state is moving through the normal pace of dried flower at first and Vapes and edibles and whatnot and then drink. So, um, it's, uh, it's a super strong state. We think we can penetrate quite well. We've had good success with the formulations in, uh, in, uh, Canada. So we'll be pouring those into the US market and then producing for that MSO and then other MSOs, uh, as we moved out and, and they really sell it. Gummy sales in, uh, in Michigan sell out within two days on shelf. So, you know, there's, uh, there's a shortage of good quality edible products and vape products. The price of cannabis is coming down there. So they have the, uh, the, uh, that a shortage like Ontario and everywhere else did when, uh, when we started at this one legalization. Now the ground was catching up to demand and they're probably overproducing, which is great for guys like us. So we can, uh, buy some, uh, inputs a little bit cheaper. So, uh, we'll be able to retain their margin and you can charge a little bit, uh, differently in the US, you know, there's not a cap. And the, the provincial enemies cap you on premium product or whatnot. So the market can flow naturally to where it should be for the quality of the product. So, um, you know, we're pretty excited that, uh, people will recognize our quality in our vape and our chew product. And we're going to do some live resin down there also is another product we're bringing in. So, uh, we'll have a live resin vape and whatnot, uh, entering the market and then we'll actually bring that into Canada at the, uh, quarter one, two, uh, 2022 in Canada. Wow. This is a huge update from Ben Nikoleski, the CEO of pure extracts symbol pull in Canada PULL in America, PR XTF. Now I want to talk a little bit about Tilray. Tilray just reported huge numbers. And the stock is doing really well today. It's up over 20% seems to be bringing the entire cannabis sector up with them. Do you think that this could be the beginning of a trend reversal for cannabis stocks? Because it seems as though we've had like a huge retrace across the board for the whole sector, despite the fact that Biden was very pro cannabis and, you know, was one of the keys to winning the election. And to be quite frank, since he's, since he's been in, in, in power, there's really been no change. Like nothing has really moved forward with legalization of cannabis in the United States. Do you see a trend reversal coming for cannabis? Because the numbers that Tilray reported were huge, like over 140 million for the quarter. Now, obviously that included Afria numbers for the first time. So that's obviously why it was such a big number, but still for Tilray to report 140 million for the quarter, that gives them a run rate of about 560 million a year, half a billion a year. Yeah, we were the first ones to talk about Tilray pre IPO like a couple of years ago. So to watch Tilray go from, I guess it was $17 when it went to as high as 300, then it came all the way back down. And before today, it was trading at around 15 bucks in Canada. I know it hit $20. I'm not looking right now. It's probably, you know, just under 20 right now, 19 something. But what do you think about that? Do you think that that could be a catalyst for the entire sector? Yeah, absolutely. As you know, I sold my previous business to Tilray. So, so we have some insight. What about an insight into the way their model works, especially with the deal with Afria? I think that, you know, the market sold off too hard, you know, as Biden, you know, wasn't moving as fast as people wanted to. And they were concerned if the Canadian operators could mimic the US operators, the MSOs, and with these results, I think, you know, people will definitely be looking a little bit harder at the Canadian operation up. You know, they can generate some real revenue and some profitability on the road on Canadian large scale cannabis players, you know, like the Tilray's and, you know, like Constellation and Canopy and whatnot. And then guys like us, like, you know, we can make money, you know, in the marketplace and they have, you know, Tilray has some exposure to international and some CBD in the US. So I think this is a really good turn of events for the Canadian cannabis business. And I think you're going to see over the next month or two, you know, a run up in those equities of because I really think that, you know, as Biden didn't move, I think the market always won't, you know, hopes for things to happen overnight. And I think that, you know, obviously, you know, Biden won, as you said, the one of his platforms he won on was the legalization of cannabis and he's moving towards it. They got the banking kind of sorted out so they can bank in the institutionals in the US pretty much or they're getting there. So I think I think everybody's now saying, well, they can hold their own in Canada. They can make, you know, they can have real revenue and now, you know, obviously as the US moves forward, you know, they'll be even stronger. So I think you're going to see the Canadian equities now start to turn. Yeah. And I think like I've been talking to people within our trading community and our members in our trading club about the fact that typically, especially for small caps, September until January seem to be the best time of the year. So we are going to go into the best time of the year for small caps and historically cannabis stocks have always done really well between September and January. Yeah. So that seems to be the time when we have really huge growth and then for some reason it's always really slow in the summer. Typically, typically from the spring to the summer, we have a slowdown in the cannabis sector. It seems like it's been like that since the beginning. I feel like we're setting up for that again. You know, everybody knows that. So, you know, market makers or investors, you maybe take their money off the table and then, you know, in September, when everyone's back to school, kids are back to school, you know, a lot of investors are back at their trading desks. Investors are just looking at stocks again. Maybe that's when they start coming back in aggressively and looking for price appreciation. What do you think about that? Yeah, you know, there's definitely been a trend to, you know, if there's value in the equity, the traders are going to trade it. That's the way I look at it. So, you know, there's definitely been a sector always, you know, for the last, you know, X number of years, you're 100%, right? There's definitely been that fall to winter trade for sure. You know, we've seen a nice little uptick in our equity over the last little while. I think we've got, you know, a long way to go to be where we should be. But definitely, definitely, you know, started, you know, generating some revenue and a lot of the smaller caps have started to do the same. They're, you know, the folks that shouldn't be there are no longer there. And the companies that have real business models will flourish. But that's the nature of, you know, Bay Street and Wall Street. People go to the Hamptons. People go to Muskokas, you know, they're with their families. It's not necessarily top of mind. This is where a lot of my investors are shopping, to be honest with you. There's great value right there. You know, us being one of them. But just in the sector alone, this is when, you know, you start building in July and August, your book, and then hopefully by September, you have your position set near a way to the races. So, you know, we've seen in our clubs, you know, a lot of people, you know, moving into positions because it's just, you know, they're kind of languishing around. So, and that's, you know, we saw a bump in our equity because of some of the U.S. trades, you know, it was, we're undervalued for entering, obviously, Michigan, you know, even at, you know, 40 cents. You know, that's not even the value of a Michigan trade, right? For the whole company. So, you know, there's definitely, we're never going to see a good market, I think, in, you know, come September. I think, you know, us personally, we're going to continue to see appreciation in our equity value just because of the sales that, you know, we went from, you know, non-revenue producing, you know, in, in March to, you know, now we're signing every province that we can, we can ship to, you know, as with you. So, you know, we're worth it. No, I love it. You know, I don't look at much, like some people look at the stock and they think that, that tells the whole story and sometimes it does. I like to look at the fundamentals of a company and I really believe that that is the true secret as far as being a good investor. You have to be able to understand the fundamentals of the company. Your fundamentals are sound. You guys have a tight float company. You guys are growing your revenue. You guys are expanding like you said in major markets and when you look at your stock and we can talk about it right now, like your IPO was around 40 cents, 44 cents. I remember like it was yesterday was in November. We broke it first. You guys went to about a dollar, which was huge return for investors. Everybody was able to double their money, great return for investment. And then like everybody else at that time when you hit your highs, it was kind of right when the market was at its peak, you know, mark was at its peak. I would say in February of 2021. And then we saw small caps specifically small caps start to kind of slowly bleed down slowly, bleed down and they've been doing that ever since. Now some stocks have made some sneak attacks. You guys included you guys went all the way down to 20 cents where you were very undervalued. And since then you've pretty much doubled in price with incredible volume. The volume has been incredible where you were trading like five to ten times daily average volume. Yeah. You explain where that came from. Do you know where it came from? Is it just investors saying like you said, you know, this is too cheap. Let me get in. Is it institutions saying it's too cheap. Let me get in. Or were you wondering where that came from? Just like me. Well, you always wonder where, you know, it came from some days, but part of it was US buying. To be honest with you, there was a lot of US investors in small institutions that have been looking at us and said like a 20 cents, you know, this thing is definitely a buy. It's way undervalued for what they're doing. And that was a lot of the, you know, big volume, you know, numbers that came up were US investors in small institutions buying on the saying, you know what they're telling us that revenue is being booked and nobody is waking up at the switch. So they, you know, they, they woke up from the switch in the big day, you know, from those big day of trading and said, you know, if somebody is going to give it away at 20 cents, we're going to take it. Right. So that was a lot of that. And, and the cannabis business, you know, and from looking at me, I'm going to do all these things too. You know, you never, they never, a lot of them didn't do it. Right. So a lot of people got frustrated on, you know, we did a lot of stuff during COVID, which, you know, hats off to my management team without my folks. We can never get here. So it took a little longer. And, you know, I, you know, released a newsletter to our investor groups to say, like, you know, we're probably, you know, took an extra corner with COVID just to get through health Canada, get the provinces, your shipping product to people's homes and whatnot for listings and whatnot for the provinces. So it just takes a little bit more time. So I think there was some of that. There was the kind of frustration selling where, you know, people get frustrated in the trade. But, you know, the large volume came from investors waking up saying, at 20 cents, this, the math doesn't work. We got over small and we did some financing along the way. And, you know, people that want to trade, you know, for, to say, good just trading. So, you know, they made a little bit of money and they sold us down, which is fine. But, you know, I still think we're a really good buy personally, you know, from where we sit and, you know, hats off to the investor groups that came and supported us, you know, at that 20 cents, you know, we knew the volume was going to come and they were looking at us. We didn't know that it would show up all, you know, in a relatively short period of time. But that goes obviously, you know, my, we have a lot of great investors, you know, we have, I think, 7,500 investors the last count. Wow. So, yes, a lot. There's a lot. So, we, we're super happy with the distribution, lots of, you know, multi geographies, both Canada, the US, you know, we have a German listing also. So, we're super happy about the distribution. So, there's not, you know, one party that's, you know, holding the stock that bought that volume. So, you know, we think that there's, there's a lot more gas in the tank for what we're doing. Once we can divulge who the MSO is and we start generating revenue in Michigan, that's a game changer. You know, there's not, there's not a lot of Canadian guys that can say that they're in the, you know, the hottest market in the US from an extraction perspective. So, that to me is worth, you know, my view really doesn't matter what it's worth. You know, the market will dictate that, but it's worth my market cap at least, you know, to be able to produce in Michigan. If we look at Michigan producers, I think the cheapest one out there is red, white and blue. And I think they're like 100 million plus market cap, right? So, they're really, they're not really even producing yet in the Michigan market, right? So, they're just getting going. So, you know, we're a known entity, we're producing in Canada we have revenue and we're at 40 cents, right? So, I don't care how you split the math, still, still a buy. So, we'll see what happens. But that's, that's the way we look at it. Well, another thing that I want to talk about is I'm a huge fan of cannabis, but I'm also a huge fan of psychedelics. I love disruptive sectors. So, you guys are not only becoming a huge player in cannabis and I do believe, like you said, you're undervalued, under-appreciated, under-exposed. In every way you look, it's undervalued. What about psychedelics? We've just seen Mind Medicine up-list to the NASDAQ. We've seen Saibin announce that they're going to be up-listing to the New York Stock Exchange. Field Trip just announced that they're going to be moving up to the Senior Exchange. That's three companies now that are all psychedelic companies that are going to be on a Senior Exchange. You have any updates or any news on where you guys are at with your psychedelics out of your business? Yeah, absolutely. So, still a really important part of our business and glad you brought that up. Obviously, the functional part of the business is picking up steam. We sell on Amazon our functional products under pure mushrooms. That's been going really well for us and it gives us the ability to do development on non-psychedelic mushroom-based products that we can then use in other products. So, we signed a LOI for a clinical trial with science, with a P that also out of there in Canada and in South Africa. So, we're working with them on a clinical trial with a major university. So, we're still working on fast-acting agents for depression and anxiety in the psychedelic part of the arena. So, we're still working hard in that area because I've seen some of the changes that go on when a patient takes psilocybin and the effects that it has on people, it's amazing. Like 100% from a medical perspective, it changes these people with a week, two weeks worth of dosing. It really reprograms the brain in a lot of people and it's an amazing product. Super happy that we're involved and we're doing some clinical trials and as we we're perfecting expression capability. We apply for a dealer's license, as you know. So, we're ready to go to finish that space within the facility. So, we're continuing to push that forward. We're going to release some more functioning products next quarter in the marketplace. So, we're super excited about that. Yeah, I'm excited about it as well. If you had anything left that you wanted to share with the audience to your 7,500 investors that won't get a chance to see this video, what would it be? It would be stay tuned. You know what? We're a disruptive company. We like to develop you know, new innovative products both on the mushroom side and on the cannabis side. And you know, that's that's something that my management team spends a lot of time on product development and bringing new innovative things to market. You know, our chicklet packed gummy first in Canada. You know, we developed that. Gummies were all over Canada. Everybody's putting a cheap pouch. We said, you know what? You know, gummies may be all packed with this packaging will be, you know, disruptive from doesn't have any issue with Keith doesn't have any issue with those things because it's an own little, you know, cylinder within a chicklet pack. So, you know, look for more products like that coming to market. And then obviously on the on the psychedelic side, you know, we're doing some pretty neat stuff in the clinical trial area. And that'll be, you know, pretty pretty many it can't be too much about that, but we're definitely pushing forward on that area. We've got some neat stuff coming. So stay tuned for that. Well, thank you for joining us today. Ben Nikoleski, the CEO of Pure Extracts symbol is Pull in Canada, P-U-L-L. We are XTF, a company that I believe is undervalued, underappreciated, underexposed, growing in Canada, growing into the Michigan market, a company that's in the cannabis side and the psychedelic side and still priced right around 40 cents in Canada. So I think that this guy's a limit for you guys. And thank you for joining us today, Ben. Rich, thanks for having me. Love being on the show and if any of your investors, you know, have any questions or whatnot, you know, info at PureExtracts.com, they can send their questions in. We're happy to respond to them. Thank you for your time today, Ben. And for those of you guys that are watching, you're not winning, you're not watching, we bring you the winners and we bring them to you first. If you like the video, please smash the like button, comment them below, share the video everywhere and subscribe. And a quick disclaimer, Rich TV Live is strictly for information education purposes. Please do your due diligence. Do your research. You know, we do before you invest in anything that we talk about here in Rich TV Live. In saying that, I think this is a great company that is undervalued that has a great future with a strong management team, tight share structure, growing revenue, doing all the right things. And I believe we'll see you again soon, hopefully with a higher share price or revenue and more big news. Love to invite you back anytime you have big news, Ben. You'll see me soon. All right, all right. Enjoy the rest of your summer and hope to see you soon. And for those of you guys that are watching, have a nice day, everybody. Thanks very much.